- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02215564
Bordetella Pertussis Carriage in College-aged Students
May 27, 2015 updated by: J. Owen Hendley, MD, University of Virginia
The objective in this observational cohort study of young adults sampled at three intervals during the academic year is to ascertain if there is carriage of B. pertussis in asymptomatic individuals.
We hypothesize that in asymptomatic college students there is no carriage of B. pertussis detectable by polymerase chain reaction (PCR) assay.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
College-aged students/young adults
Description
Inclusion Criteria:
- Age 18 and above
- Not immunosuppressed
- Not HIV positive (not known to be/self-reported)
- Able to tolerate swab procedures
- Able to provide consent
Exclusion Criteria:
- No antimicrobial or immunosuppressive medications taken for chronic conditions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
No treatment
Young adults tested by PCR for B. pertussis carriage
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with B. pertussis by PCR in nasopharyngeal sample at first timepoint
Time Frame: 30 minutes
|
Participants will be tested for B. pertussis by PCR at one visit in October 2014, 30 minutes.
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with B. pertussis by PCR in nasopharyngeal sample at second timepoint
Time Frame: 30 minutes
|
Participants will be tested for B. pertussis by PCR at one visit in January 2015, 30 minutes.
|
30 minutes
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with B. pertussis by PCR in nasopharyngeal sample at third timepoint
Time Frame: 30 minutes
|
Participants will be tested for B. pertussis by PCR at one visit in April 2015, 30 minutes.
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Nuolivirta K, Koponen P, He Q, Halkosalo A, Korppi M, Vesikari T, Helminen M. Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J. 2010 Nov;29(11):1013-5.
- Zhang Q, Yin Z, Li Y, Luo H, Shao Z, Gao Y, Xu L, Kan B, Lu S, Zhang Y, Li M, Liu M, Yao P, Zhao Z, He Q. Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: a cross-sectional study. Scand J Infect Dis. 2014 Apr;46(4):280-7. doi: 10.3109/00365548.2013.878034. Epub 2014 Feb 13.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (ANTICIPATED)
June 1, 2015
Study Completion (ANTICIPATED)
August 1, 2015
Study Registration Dates
First Submitted
August 6, 2014
First Submitted That Met QC Criteria
August 12, 2014
First Posted (ESTIMATE)
August 13, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
May 28, 2015
Last Update Submitted That Met QC Criteria
May 27, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17545 (Canadian Orthopedic Foundation Department of Surgery Internal Research Fund)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carriage of Bordetella Pertussis
-
University Hospital, GhentGlaxoSmithKline; Sanofi Pasteur, a Sanofi Company; Novartis Vaccines; University... and other collaboratorsCompletedPrevention of Infections With Bordetella PertussisBelgium
-
Public Health EnglandCompletedNasal Carriage of PneumococciUnited Kingdom
-
IMU University, MalaysiaRecruitingNasopharyngeal Carriage of Streptococcus PneumoniaeMalaysia
-
Institut PasteurAgence de Médecine Préventive, France; Institut Pasteur de Madagascar; Institut...CompletedBordetella Pertussis, Whooping CoughCambodia, Madagascar, Togo
-
Institut PasteurSanofi Pasteur, a Sanofi Company; Institut Pasteur of Cote d'IvoireCompletedBordetella Pertussis, Whooping CoughCôte D'Ivoire
-
Institut PasteurHopital Universitaire Robert-Debre; Hospices Civils de Lyon; Centre Hospitalier... and other collaboratorsRecruitingBordetella Pertussis, Whooping CoughFrance
-
ILiAD BiotechnologiesCompletedBordetella Pertussis, Whooping CoughUnited Kingdom, Australia, Costa Rica
-
University of TurkuGlaxoSmithKline; Sanofi Pasteur, a Sanofi CompanyCompleted
-
Assistance Publique - Hôpitaux de ParisRecruitingRectal Carriage of Carbapenemase Producing-EnterobacteriaceaeFrance
-
ILiAD BiotechnologiesCompletedPertussis/Whooping Cough | Bordetella Pertussis, Whooping CoughUnited Kingdom